2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
---|---|---|---|---|
营业收入(元) | ||||
干混悬剂(元) | - | 2,793,026.57 | - | 1,672,338.10 |
胶囊剂(元) | 844,578.23 | 522,379.64 | 899,051.32 | 374,362.83 |
颗粒剂(元) | 45,846,460.43 | 26,201,177.28 | 45,999,087.36 | 20,669,139.29 |
口服液(元) | 91,476,698.78 | 53,027,425.24 | 70,768,925.51 | 28,224,124.29 |
片剂(元) | 30,295,643.10 | 16,473,678.55 | 33,100,057.58 | 11,909,263.17 |
原料药(元) | 30,308,349.10 | 23,090,649.13 | 20,493,951.69 | 4,315,780.69 |
注射剂(元) | 112,207,747.79 | 51,158,819.95 | 82,784,203.91 | 41,878,103.89 |
干悬混剂(元) | 6,202,703.64 | - | 5,723,174.07 | - |
其他业务(元) | - | - | - | 207,076.46 |
其他(元) | 10,400,475.06 | 8,735,813.97 | 4,342,878.31 | - |
营业成本(元) | ||||
干混悬剂(元) | - | 2,212,736.71 | - | 1,485,447.09 |
胶囊剂(元) | 9,332.12 | 3,448.68 | 37,428.64 | 6,462.97 |
颗粒剂(元) | 30,020,128.90 | 17,714,715.71 | 29,051,776.59 | 12,779,147.62 |
口服液(元) | 46,287,056.51 | 25,730,862.12 | 39,042,506.22 | 17,124,904.42 |
片剂(元) | 20,523,609.48 | 11,681,728.10 | 25,893,511.11 | 8,938,057.96 |
原料药(元) | 28,588,556.13 | 22,265,768.79 | 19,336,265.20 | 3,751,274.04 |
注射剂(元) | 89,824,503.03 | 37,965,383.91 | 53,559,756.26 | 26,897,194.73 |
干悬混剂(元) | 5,013,437.60 | - | 5,045,187.85 | - |
其他业务(元) | - | - | - | 164,901.74 |
其他(元) | 1,640,174.53 | 2,776,205.89 | 518,662.79 | - |
毛利(元) | ||||
干混悬剂(元) | - | 580,289.86 | - | 186,891.01 |
胶囊剂(元) | 835,246.11 | 518,930.96 | 861,622.68 | 367,899.86 |
颗粒剂(元) | 15,826,331.53 | 8,486,461.57 | 16,947,310.77 | 7,889,991.67 |
口服液(元) | 45,189,642.27 | 27,296,563.12 | 31,726,419.29 | 11,099,219.87 |
片剂(元) | 9,772,033.62 | 4,791,950.45 | 7,206,546.47 | 2,971,205.21 |
原料药(元) | 1,719,792.97 | 824,880.34 | 1,157,686.49 | 564,506.65 |
注射剂(元) | 22,383,244.76 | 13,193,436.04 | 29,224,447.65 | 14,980,909.16 |
干悬混剂(元) | 1,189,266.04 | - | 677,986.22 | - |
其他业务(元) | - | - | - | 42,174.72 |
其他(元) | 8,760,300.53 | 5,959,608.08 | 3,824,215.52 | - |
毛利率(%) | ||||
干混悬剂(%) | - | 20.78 | - | 11.18 |
胶囊剂(%) | 98.90 | 99.34 | 95.84 | 98.27 |
颗粒剂(%) | 34.52 | 32.39 | 36.84 | 38.17 |
口服液(%) | 49.40 | 51.48 | 44.83 | 39.33 |
片剂(%) | 32.26 | 29.09 | 21.77 | 24.95 |
原料药(%) | 5.67 | 3.57 | 5.65 | 13.08 |
注射剂(%) | 19.95 | 25.79 | 35.30 | 35.77 |
干悬混剂(%) | 19.17 | - | 11.85 | - |
其他业务(%) | - | - | - | 20.37 |
其他(%) | 84.23 | 68.22 | 88.06 | - |
收入构成(%) | ||||
干混悬剂(%) | - | 1.53 | - | 1.53 |
胶囊剂(%) | 0.26 | 0.29 | 0.34 | 0.34 |
颗粒剂(%) | 14.00 | 14.40 | 17.42 | 18.92 |
口服液(%) | 27.92 | 29.14 | 26.80 | 25.83 |
片剂(%) | 9.25 | 9.05 | 12.53 | 10.90 |
原料药(%) | 9.25 | 12.69 | 7.76 | 3.95 |
注射剂(%) | 34.25 | 28.11 | 31.34 | 38.33 |
干悬混剂(%) | 1.89 | - | 2.17 | - |
其他业务(%) | - | - | - | 0.19 |
其他(%) | 3.17 | 4.80 | 1.64 | - |
毛利构成(%) | ||||
干混悬剂(%) | - | 0.94 | - | 0.49 |
胶囊剂(%) | 0.79 | 0.84 | 0.94 | 0.97 |
颗粒剂(%) | 14.98 | 13.77 | 18.50 | 20.71 |
口服液(%) | 42.76 | 44.28 | 34.63 | 29.13 |
片剂(%) | 9.25 | 7.77 | 7.87 | 7.80 |
原料药(%) | 1.63 | 1.34 | 1.26 | 1.48 |
注射剂(%) | 21.18 | 21.40 | 31.90 | 39.32 |
干悬混剂(%) | 1.13 | - | 0.74 | - |
其他业务(%) | - | - | - | 0.11 |
其他(%) | 8.29 | 9.67 | 4.17 | - |